Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Comment by Moroseon Nov 14, 2012 2:27pm
174 Views
Post# 20599981

RE: quick double

RE: quick double

I am quite sure it will be be a quick double right after it reaches 15 to 20 cents.......

I made a prediction in september about the share price going to 30 cents and I believe I was a little bit optimistic.

Institutional holding went from 38% to 18 % in a matter of weeks and now shareholders are selling for tax loss money ,of course if you stille believe in the company it is a good time to add to your holding and it will even be better when the share price goes to 20 cents.

Us , shareholders we have been left alone by management.

Could a seasoned and experienced investor please tell me  why in hell there is no letter to shareholders published by Diagnocure for explaining the total darkness in wich we are entangle, it looks like they are really happy with the share price drifting to agony.

Morose

 

 

 

 

 

 

 

 

<< Previous
Bullboard Posts
Next >>